Maximizing Bispecific Antibody Efficacy in Solid Tumors & Overcoming the Tumor Microenvironment
Time: 9:35 am
day: Pre-Conference Day Workshop B
Details:
- Leveraging innovative research to identify promising targets within the tumor microenvironment for bispecific antibody drugs
- Optimizing bispecific antibody design and functionality for enhanced tumor penetration
- Engineering strategies to enhance bispecific antibody penetration into the solid tumor microenvironment
- Tailoring antibody formats and binding affinities for optimal target engagement and therapeutic effect
- Evaluating preclinical models and predictive tools for assessing bispecific antibody penetration and activity in solid tumors
- Addressing hurdles in translating preclinical bispecific success to clinical efficacy in solid tumor therapy
- Discover innovative strategies to optimize antibody design, overcome translational challenges, and propel the field towards effective clinical solutions for combating solid tumor progression
